Polymyalgia rheumatica: The mess we are now in and what we need to do about it

Arthritis Care and Research

Volumn 55, Issue 4, 2006, Pages 518-520

  Dasgupta, Bhaskar ^a,d   Hutchings, Andrew ^b   Matteson, Eric L ^c  

^a SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Mayo Clinic College of Medicine   (United States)

^d BASILDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID;

ACUTE PHASE RESPONSE; ANOREXIA; ARTHRITIS; CARPAL TUNNEL SYNDROME; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG NOMENCLATURE; DRUG RESPONSE; ECHOGRAPHY; EDEMA; EDITORIAL; ERYTHROCYTE SEDIMENTATION RATE; FEVER; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; IMAGE ANALYSIS; JOINT STIFFNESS; NECK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRACTICE GUIDELINE; RHEUMATIC POLYMYALGIA; RISK FACTOR; SHOULDER PAIN; SYMPTOM; TREATMENT INDICATION; WEIGHT REDUCTION;

ADRENAL CORTEX HORMONES; HUMANS; PAIN; POLYMYALGIA RHEUMATICA;

EID: 33744826871     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.22106     Document Type: Editorial

References (12)

1. Walsh LJ, Wong CA, Pringle M, Tattersfield AE. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 1996;313:344-6.
2. Chakravarty K, Elgabani SHS, Scott DGI, Merry P. A district audit on the management of polymyalgia rheumatica and giant cell arthritis. Br J Rheumatol 1994;33:152-6.
3. Bird HA, Esselinckx W, Dixon ASJ, Mowat AG, Wood PHN. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
4. Brooks RC, McGee SR. Diagnostic dilemmas in polymyalgia rheumatica. Arch Intern Med 1997;157:162-8.
5. Blaauw AA, Schuwirth LW, van der Vleuten CP, Smits F, van der Linden S. Assessing clinical competence: recognition of case descriptions of rheumatic diseases by general practitioners. Br J Rheumatol 1995;34:375-9.
6. Chuang TY, Hunder GG, Ilstrup DM, Kirkland LT. Polymyalgia rheumatica: a 10 year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
7. Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum 1984;13:322-8.
8. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5.
9. Dasgupta B, Kalke S. Polymyalgia rheumatica. In: Isenberg D, Maddison P, Woo P, Glass D, Breedveld FC, editors. Oxford textbook of rheumatology. 3rd ed. Oxford: Oxford University Press; 2004. p. 977-83.
10. Caporali R, Montecucco C, Epis O, Bubbio Pallavicini F, Maio T, Cimmino MA. Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR like onset: a prospective study. Ann Rheum Dis 2001;60:1021-4.
11. Lopez-Hoyos M, Ruiz de Alegria C, Blanco R, Crespo J, Pena M, Rodriguez-Valverde V, et al. Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Rheumatology (Oxford) 2004;43:655-7.
12. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Ann Intern Med 2003;138:40-4.